Related by context. All words. (Click for frequent words.) 64 thoracoscopic lobectomy 64 polycythemia vera essential thrombocythemia 63 refractory colorectal cancer 62 curative therapy 62 noninvasive outpatient 61 medically inoperable 61 thymectomy 61 Trofex 61 recurrent glioblastoma multiforme 60 Fibrillex TM 60 recurrent metastatic 60 curative resection 60 Hepatocellular Carcinoma HCC 60 breast conserving lumpectomy 60 pelvic lymphadenectomy 60 adjuvant radiotherapy 60 tezampanel NGX# 60 cervical lymph node 60 precancerous condition 60 collagen vascular 60 metastatic bladder 60 biliary tract cancer 60 relapsed ALL 60 unresectable recurrent 59 LHRH receptor positive 59 systemic ALCL 59 elective PCI 59 CB2 selective receptor agonist 59 cytoreduction 59 esophageal gastric 59 recurrent NSCLC 59 chronic myocardial ischemia 59 Zemiva TM 59 commercialize CorMedix drug 59 postoperative chemotherapy 59 liver resection 59 resectable 59 Surgical resection 59 lymph node dissection 59 node dissection 58 metastatic dermatofibrosarcoma protuberans DFSP 58 Fx #A 58 leukemia lymphoma multiple myeloma 58 endocrine therapies 58 myelodysplastic myeloproliferative diseases 58 HIPEC 58 targeted radiotherapeutic 58 relapsed ovarian cancer 58 renal denervation 58 lintuzumab SGN 58 ovarian cancer chronic hepatitis 58 extrapleural pneumonectomy 58 chemoresistant 58 relapsing remitting MS RRMS 58 Dose adjustments 58 operable breast cancer 58 aromatase inhibitor therapy 58 pheochromocytoma 58 treating cancerous tumors 58 lenalidomide Revlimid R 58 riociguat 58 benign uterine 58 irinotecan oxaliplatin 58 Liver transplantation 58 pancreatic islet cell 58 autologous hematopoietic stem cell 58 including eniluracil ADH 58 R0 resection 58 thetreatment 58 tumor resection 58 MYLOTARG 58 OMP #R# 58 antiplatelet medications 58 Arranon 58 dose escalation phase 58 autologous transplants 58 benign prostatic hyperplasia enlarged 58 cystectomy 58 allogenic stem cell 58 Excellagen 57 haematologic 57 abdominal hysterectomy 57 mTOR inhibitors 57 anthracycline taxane 57 CYT# vascular disrupting 57 MAGE A3 ASCI 57 Surgical excision 57 transarterial 57 coronary arteriography 57 radical cystectomy 57 pharmacologic stress 57 MKC# MT 57 CYT# potent vascular disrupting 57 tanespimycin 57 related hematological toxicity 57 skeletal metastases 57 herpetic keratitis 57 taxane chemotherapy 57 hematologic disorders 57 TELINTRA 57 PANVAC VF 57 undergoing cardiac catheterization 57 refractory APL 57 neoadjuvant setting 57 IIb clinical trial 57 hepatic metastases 57 surgical debulking 57 reversing heparin 57 angioplasty stenting 57 SNT MC# 57 Lymph node 57 Cloretazine 57 castrate resistant 57 non resectable metastatic 57 Accelerated Partial Breast Irradiation 57 tuberous sclerosis TS 57 transplantation HCT 57 chronic thromboembolic pulmonary 57 cervical carcinoma 57 fusion enhancers 57 metastatic gastric 57 TRIOLEX HE# APOPTONE HE# 57 pain palliation 57 thoracic aortic aneurysms 57 concurrent chemoradiation 57 ADVEXIN therapy 57 bardoxolone methyl 57 lupus renal disease 57 Generx ™ 57 investigational monoclonal antibody 57 receiving immunosuppressive therapy 57 opioid analgesia 57 pulmonary hypertension PH 57 Helicobacter pylori eradication 57 MDS AML 57 metastatic renal cell 57 malignant ascites 57 nodal metastasis 57 kidney urologic 57 anti angiogenic agents 57 benign prostatic hypertrophy 56 primary percutaneous coronary 56 hematopoietic cancers 56 Peginterferon alfa 2b 56 metastatic RCC 56 lenalidomide dexamethasone 56 Voraxaze ™ 56 alvespimycin 56 APEX AMI 56 bilateral mastectomies 56 metastatic neuroendocrine tumors 56 refractory acute myeloid 56 cetrorelix pamoate 56 bladder ovarian 56 malignant pleural mesothelioma 56 deCODE ProstateCancer TM 56 subarachnoid hemorrhage SAH 56 completely resected 56 treating neuropathic pain 56 hematologic abnormalities 56 pouchitis 56 spinal metastases 56 metastatic colorectal 56 papillary renal cell carcinoma 56 RSR# 56 clot busting therapy 56 para aortic 56 portal vein thrombosis 56 metastatic malignant 56 relapsed SCLC 56 cerebral angiography 56 mutated K ras 56 haematologic malignancies 56 debulking surgery 56 triphendiol 56 Waldenstrom macroglobulinemia 56 sunitinib Sutent 56 unresectable tumors 56 androgen ablation 56 colorectal cancer liver metastases 56 Mitomycin C 56 pacemaker implantation 56 esophageal candidiasis 56 Torisel 56 Panzem R NCD 56 Zavesca R 56 Dementia Related Psychosis 56 treat enlarged prostate 56 postoperative morbidity 56 Myelodysplastic syndromes MDS 56 administered systemically 56 Liposomal Grb 2 56 preoperative chemotherapy 56 palliation 56 IV metastatic melanoma 56 chemoradiation therapy 56 Noxafil 56 PCI percutaneous coronary 56 gastrointestinal stromal tumors GIST 56 prostate carcinomas 56 colorectal liver metastases 56 neurodegenerative diseases Alzheimer disease 56 colon resection 56 systemic corticosteroid 56 metastatic carcinoid 56 hypervascular tumors 56 Certolizumab pegol 56 catheter occlusion 56 pemphigus vulgaris 56 antithrombotic therapy 56 pancreatic resection 56 atherosclerotic renal artery stenosis 56 CMV vaccine 56 liver scarring 55 receiving XGEVA 55 donor nephrectomy 55 chronic idiopathic thrombocytopenic purpura 55 resectable pancreatic cancer 55 hereditary deficiency 55 myeloablative 55 allogeneic HSCT 55 nodal dissection 55 chemoradiotherapy 55 cardiotoxic 55 metastatic malignant melanoma 55 alpha1 antitrypsin deficiency 55 treat chronic sinusitis 55 containing LABAs 55 Severe hypersensitivity reactions 55 relapsed MM 55 Phase IIb clinical trials 55 smoldering multiple myeloma 55 IV NSCLC 55 malignant polyps 55 psoriatic arthritis PsA 55 Telintra 55 hoFH 55 Phase #b/#a clinical 55 neoadjuvant chemoradiotherapy 55 trastuzumab Herceptin ® 55 dasatinib Sprycel 55 dopaminergic therapy 55 oral talactoferrin 55 IMC #B 55 sorafenib Nexavar 55 Allovectin 7 55 taxane refractory 55 urinary diversion 55 CMV disease 55 iii GTx 55 Zavesca ® 55 prostate TURP 55 hormone refractory 55 Solazed 55 MCSP respectively 55 esophagectomy 55 TOCOSOL Camptothecin 55 rALLy clinical trial 55 Torisel temsirolimus 55 smoldering myeloma 55 MGd 55 liver metastasis 55 NATRECOR ® 55 orchiectomy 55 minimally symptomatic 55 immune suppressing medication 55 either acutely decompensated 55 GnRH agonist 55 drug NP2 Enkephalin 55 dirucotide MBP# 55 hormonally sensitive 55 bowel resection 55 mycosis fungoides 55 naronapride 55 inhaled tobramycin 55 atypical Hemolytic Uremic Syndrome 55 ablative therapy 55 Venous thromboembolism 55 ANAVEX #-# [001] 55 endothelin receptor antagonists 55 lymphomas leukemias 55 asymptomatic hyperuricemia 55 AAG geldanamycin analog 55 prophylactic therapy 55 cisplatin chemotherapy 55 pre malignant lesions 55 M# rationally 55 Plaquenil 55 bortezomib Velcade 55 non splenectomized 55 pelvic malignancies 55 Neo Kidney Augment 55 PLX STROKE targeting 55 Tykerb lapatinib 55 Mepact 55 microsphere therapy 55 ticagrelor Brilinta 55 Immunotherapeutic 55 cervical lymph nodes 55 severe hepatic dysfunction 55 patientswith 55 vaginal hysterectomy 55 presymptomatic 55 invasive diagnostic 55 squalamine 55 adverse cytogenetics 55 histologies 55 occlusive disease 55 samalizumab 55 unresectable stage 55 Generx TM 55 fibrinolysis 55 investigational therapies 55 allogeneic stem cell 55 BrachySil TM 55 antiarrhythmic medications 55 MyVax ® 55 molecular chaperone regulator 55 Exherin TM 55 FUSILEV enhances 55 neoadjuvant therapy 55 Aggrastat ® tirofiban hydrochloride 55 cranial radiation 55 Stage IIIb 55 Vandetanib 55 hormonally responsive 55 cytotoxic therapy 55 intra arterial chemotherapy 55 YONDELIS 55 ICD therapy 55 rituximab Rituxan ® 55 symptomatic hyponatremia 55 tramiprosate Alzhemed TM 55 stratifying patients 55 paclitaxel Taxol R 55 adalimumab Humira 55 Trovax 55 arterial revascularization 55 IOP lowering 54 lymph node removal 54 imexon 54 PDE# inhibitors 54 intravenous cyclophosphamide 54 valve implantation 54 radiation chemoradiation 54 laproscopic procedure 54 APTIVUS ritonavir 54 Bone marrow transplant 54 bacillus Calmette Guerin BCG 54 anticlotting drugs 54 revascularization procedures 54 antiangiogenic agents 54 Oral corticosteroids 54 Radical prostatectomy 54 ductal carcinomas 54 HCV polymerase 54 Kit CD# positive 54 Pelvic inflammatory 54 ALN VSP Phase 54 palliative radiotherapy 54 noncardiac chest pain 54 catheter angiography 54 CMV infections 54 thrombo embolic 54 neoadjuvant treatment 54 immunosuppression therapy 54 glatiramer 54 squamous cell lung cancer 54 treats acute lymphoblastic 54 antiretroviral naïve 54 VEGF inhibitors 54 induce remission 54 SCENESSE ® 54 Acute myeloid leukemia 54 ELACYT 54 drug GLPG# 54 BLA filing 54 STRIDE PD 54 Gleevec resistant 54 percutaneous cryoablation 54 Colon polyps 54 Chemophase 54 androgen ablation therapy 54 antiangiogenic drugs 54 Alequel 54 Amgen Neulasta ® 54 elective percutaneous coronary 54 corticosteroid therapy 54 TORISEL TM 54 immuno therapy 54 myocardial revascularization 54 pulmonary artery banding 54 intraperitoneal therapy 54 Potiga 54 superficial basal cell carcinoma 54 Bayer HealthCare Onyx Pharmaceuticals 54 recombinant interferon 54 adenomatous polyps 54 BRAF V# mutation 54 renal scarring 54 antiepileptics 54 Adjuvant chemotherapy 54 Trofex TM 54 Aviptadil 54 OvaRex R 54 lymphadenectomy 54 TNF blocker therapy 54 pediatric acute lymphoblastic 54 canagliflozin 54 dexanabinol 54 oral picoplatin 54 vascular insufficiency 54 diabetic gastroparesis 54 KIACTA ™ 54 inhibit platelet function 54 IMA# 54 cytotoxic chemotherapy 54 budesonide foam 54 immunotherapeutic approaches 54 Li Fraumeni Syndrome 54 resistant hormone refractory 54 osteoporotic compression fractures 54 Diamyd r 54 novel emulsion formulation 54 Tasigna prolongs 54 AA Amyloidosis 54 Li Fraumeni 54 aromatase inhibitors AIs 54 Dendreon investigational 54 HepeX B 54 Pegloticase 54 percutaneous drainage 54 surgically resectable 54 Intravenous CP 54 thorough QT 54 pneumonectomy 54 concomitant antibiotics 54 relapsed leukemia 54 peritoneal cancer 54 Nicole Onetto MD 54 OnDose TM 54 EVIZON TM 54 genomic biomarker 54 Bezielle 54 Glioblastoma Multiforme GBM 54 colonoscopic 54 pancreatic enzyme replacement 54 AGILECT R 54 nonischemic 54 ruxolitinib 54 Lung transplantation 54 Temodar ® 54 cytoreductive surgery 54 Allovectin 7 ® 54 hypereosinophilic syndrome 54 EndoTAGTM 1 54 patients receiving myelosuppressive 54 defibrillator implantation 54 Aflibercept 54 recombinant PSMA vaccine 54 opioid induced constipation OIC 54 TELINTRA R 54 subconjunctival injection 54 Gliadel Wafer 54 chemosensitizer 54 visceral metastases 54 ICD implantation 54 lung resection 54 gastrointestinal mucositis 54 Inflammatory diseases 54 antimetabolite 54 sargramostim 54 Roche Herceptin 54 lupus multiple sclerosis 54 uric acid lowering 54 needle aspiration 54 antiangiogenic therapy 54 immune thrombocytopenic purpura ITP 54 ALND 54 Natalizumab 54 pancreatic prostate 54 heavily pretreated 54 renal toxicity 54 anthracycline containing 54 Evoltra TM 54 Archexin 54 fibrinolytic therapy 54 nephrectomy 54 advanced medullary thyroid 54 oral methylnaltrexone 53 5 fluorouracil leucovorin 53 ischemic cardiac 53 external beam radiotherapy 53 refractory AML 53 TBC# 53 Coronary angiography 53 Aplidin 53 5-fluorouracil/leucovorin 53 stage IIIB IV 53 APTIVUS r 53 edifoligide E2F Decoy 53 aflibercept VEGF Trap 53 sacral nerve stimulation 53 Evoltra ® 53 perioperatively 53 coronary revascularization 53 paclitaxel cisplatin 53 heterozygous FH 53 SinuNase ™ 53 nephron sparing surgery 53 refractory Hodgkin 53 Asentar 53 Uterine fibroid embolization 53 Troxatyl 53 hematological malignancy 53 radiotherapy RT 53 enucleation 53 neoadjuvant radiation 53 ALK inhibitors 53 motesanib 53 colonography 53 endobronchial 53 atherothrombosis 53 tolevamer 53 Alemtuzumab 53 alemtuzumab Campath 53 interferon therapy 53 Excellarate product 53 underwent liver transplantation 53 Kidney transplantation 53 renoprotective 53 Recurrent Glioblastoma 53 Parkinsonian Syndromes 53 R sorafenib tablets 53 Liver transplants 53 intravesical therapy 53 leiomyomas 53 rALLy 53 hormone deprivation 53 unsedated colonoscopy 53 Fabry Disease 53 Acute Radiation Syndrome ARS 53 myelofibrosis 53 postoperative atrial fibrillation 53 Edurant 53 Vidaza azacitidine 53 hematopoietic cell 53 thoracic aneurysms 53 postoperative pulmonary 53 mTOR inhibition 53 metastatic kidney 53 taxane chemotherapy administered 53 hyperphenylalaninemia HPA due 53 Nissen fundoplication 53 Pruvel 53 biliary stones 53 Panzem R 53 Excellarate TM 53 conformal radiotherapy 53 Relapsing remitting MS 53 renal tumors 53 severe hypersensitivity reactions 53 preventive mastectomies 53 EVIZON TM squalamine lactate 53 subcutaneous immunoglobulin 53 inhaled bronchodilators 53 adrenalectomy 53 Kinoid 53 diagnostic molecular imaging 53 histamine dihydrochloride 53 esophagogastric 53 r hGH 53 Lisofylline 53 ZOLINZA 53 idursulfase 53 invasive candidiasis 53 recurrent glioblastoma multiforme GBM 53 trastuzumab Herceptin 53 primary immunodeficiency PI 53 mycophenolate 53 pamidronate 53 anti botulism antibody 53 Zevalin consolidation 53 Heavy menstrual bleeding 53 Bone marrow transplantation 53 gastrointestinal stromal tumors 53 spontaneous regression 53 Intravenous immunoglobulin 53 adjuvant cisplatin 53 hereditary antithrombin deficient 53 nonsurgical treatments 53 oral anticoagulation 53 surgical revascularization 53 Auxilium transmucosal film 53 Sentinel node biopsy 53 initiate Phase IIa 53 TNF blocker 53 metastatic uveal melanoma 53 postoperative radiotherapy 53 Abrupt discontinuation 53 chemotherapy cisplatin 53 anagrelide 53 Carotid stenting 53 TASKi3 53 equivocal appendicitis 53 CINTREDEKIN BESUDOTOX 53 sunitinib malate 53 invasive carcinoma 53 acute mania 53 undergo percutaneous coronary 53 SUTENT ® 53 zileuton injection 53 humanised monoclonal antibody 53 PLX MS 53 erlotinib Tarceva 53 immunosuppressive medication 53 Zemplar Capsules 53 metastatic pancreatic 53 pancreatic ductal 53 curative therapies 53 reduce serum phosphate 53 interventional therapies 53 Phenylketonuria PKU 53 Proellex TM 53 GRNOPC1 contains 53 patients undergoing CABG 53 malabsorptive 53 neurogenic bladder 53 angiogenic therapy 53 THR beta agonist 53 acetonide FA 53 phase IIb trial 53 KRN# 53 diabetic kidney 53 Proxinium TM 53 recurrent herpes labialis 53 XP# XP# 53 agent VDA 53 metastatic renal 53 GERD migraine headaches 53 R lenalidomide 53 lymphatic mapping 53 NEUMUNE 53 adenovirus infections 53 iron chelation therapy 53 oropharyngeal candidiasis OPC 53 epidural steroid injection 53 anthracycline therapy 53 medically refractory 53 antianginal 53 chronic hemodialysis 53 GVAX Pancreas Vaccine 53 refractory gastrointestinal stromal 53 glycoprotein IIb IIIa inhibitor 53 recurrent epithelial ovarian 53 hematological diseases 53 intravenous bisphosphonates 53 invasive aspergillosis 53 Vertex hepatitis C 53 Daclizumab 53 thrombin inhibiting aptamer 53 candidate REP# 53 eosinophilic asthma 53 androgen deprivation 53 electrical cardioversion 53 Fibrillex 53 noninvasive painless 53 metastatic lymph nodes 53 Triapine R 53 MIST II 53 vinorelbine tartrate 53 MMP inhibitors 53 cervical prostate 53 gynecologic surgery 53 urothelial cancer 53 commercialize deforolimus 53 Balloon sinuplasty 53 midstage trials 53 neovascularisation 53 tumors GIST 53 skin sparing mastectomy 53 IIIA NSCLC 53 Tyrima 53 Zytiga 53 UPPP 53 pediatric malignancies 53 renal flares 53 refractory angina 53 nonproliferative 52 treatmentof 52 revascularization procedure 52 OVATURE 52 systemic fungal infections 52 de novo kidney transplant 52 decompensated cirrhosis 52 adenomatous 52 immunomodulatory therapy 52 Phase #/#a trial 52 intraductal 52 maximally tolerated lipid lowering 52 rhIGF-I/rhIGFBP-3 52 GnRH agonists 52 Vincristine 52 ASONEP ™ 52 midstage clinical 52 mg/m2 cohort 52 Lofexidine 52 reintubation 52 weekly subcutaneous injections 52 opioid naive 52 IMPACT DCM 52 urothelial carcinoma 52 exocrine pancreatic insufficiency EPI 52 TEMODAL 52 colorectal lung 52 carotid artery stenting 52 Tesmilifene 52 oral clodronate 52 symptomatic fibroids 52 abnormal clotting 52 Nikolai Statkevich Vitaly Rymashevsky 52 adjuvant colon cancer 52 inhaled liposomal ciprofloxacin 52 aldosterone antagonists 52 homozygous familial hypercholesterolemia 52 CCR5 inhibitors 52 postoperative AF 52 paclitaxel poliglumex 52 systemic immunosuppressive drugs 52 tamoxifen Nolvadex ® 52 hemoglobinopathies 52 HERCEPTIN 52 invasive lobular carcinoma 52 anticancer treatments 52 herpes zoster shingles 52 Flexi Scope 52 breast endometrial 52 Zybrestat 52 sentinel lymph node biopsy 52 advanced hepatocellular carcinoma 52 antibiotic prophylaxis 52 proliferative diabetic retinopathy 52 nephrectomies 52 genitourinary GU 52 immunodeficiency disorders 52 dyslipidemia hypertension diabetes 52 Lixivaptan 52 secondary amenorrhea 52 GIST tumors 52 venous thromboembolic events 52 radical nephrectomy 52 empiric therapy 52 bladder carcinoma 52 Panzem 52 BRAF mutant 52 visit www.rtanswers.org 52 unruptured aneurysm 52 ovulation induction 52 acyclovir Lauriad R 52 fibrate drugs 52 mRCC 52 SIADH 52 neuroendocrine cancers 52 IRX 2 52 rufinamide 52 vaginally administered lidocaine 52 choroidal vasculopathy 52 previously untreated follicular 52 MyVax personalized immunotherapy 52 rt PA 52 recurrent glioblastoma 52 injectable investigational 52 metastatic GIST 52 HCV antiviral 52 recurrent metastatic ovarian cancer 52 opioid induced bowel dysfunction 52 cutaneous lupus 52 Exalgo TM 52 HIV coinfected 52 Vorapaxar 52 R vitespen 52 MIRAPEX ER 52 periodically reassessed 52 symptomatic paroxysmal AF 52 interferon ribavirin 52 PRIMO CABG 52 cardiotoxic effects 52 female endoscopist 52 alkylating agent 52 Cimzia TM 52 T1c 52 diabetic retinopathy DR 52 FOLFOX chemotherapy 52 lucinactant 52 Ivanhoe Newswire Patients 52 metastatic sarcomas 52 erlotinib Tarceva ® 52 ovarian adnexal mass 52 CA9 SCAN 52 Insegia 52 triggers apoptosis programmed 52 diagnostic workup 52 Urocortin 2 52 perioperative complications 52 Idera Pharmaceuticals develops 52 transurethral resection 52 DAC HYP 52 vandetanib 52 moderate renal impairment 52 drugable targets 52 Erythropoietic therapies may 52 Balamuthia 52 Panzem ® 52 adjuvant therapies 52 Radiofrequency ablation 52 biomarker discovery validation 52 AQ4N 52 clevidipine 52 neoplastic cells 52 upper endoscopy 52 Annamycin 52 conventional angiography 52 candidemia 52 decompressive surgery 52 postsurgical 52 VCUG 52 methotrexate therapy 52 Zavesca r 52 Aryplase 52 clazosentan 52 AA amyloidosis 52 GRN# 52 clinically localized prostate 52 forodesine 52 Nonsurgical 52 faropenem medoxomil 52 rtPA 52 Sudhir Agrawal D.Phil 52 fallopian tube carcinoma 52 omacetaxine mepesuccinate 52 drug figitumumab 52 Phase lll 52 deCODE AF TM 52 pharmacogenomic translational research 52 Cancidas 52 KETEK 52 recombinant enzyme 52 phase IIb clinical 52 undergo radical prostatectomy 52 Hedgehog inhibitor 52 Phase IIb III 52 delay bone metastases 52 Nothing Wadden 52 docetaxel Taxotere ® 52 egg retrieval 52 Cx# [002] 52 Hormonal therapy 52 nonmyeloablative 52 transrectal ultrasound guided 52 Steven R. Deitcher 52 PEG PAL 52 allogeneic transplant 52 Papillary 52 EECP ® therapy 52 Cabazitaxel 52 superficial bladder cancer 52 mild hepatic impairment 52 aripiprazole Abilify 52 mTOR kinase 52 Adjuvant therapy 52 signal transduction inhibitors 52 Golimumab 52 Stage IIB 52 immune dysregulation 52 cholecystectomy 52 postoperative infections 52 chemotherapy radiotherapy 52 reimplantation 52 humanized therapeutic 52 POSIDUR TM 52 sitaxsentan 52 demonstrated antitumor activity 52 carotid artery blockage 52 FluCide 52 OncoVex 52 severe oral mucositis 52 axillary dissection 52 retinal vein occlusion induced 52 anthracycline unless 52 Sebivo 52 intravenous iv 52 bilateral oophorectomy 52 MRgFUS 52 Factor VIIa 52 Degarelix 52 chronic ITP patients 52 HER2 positive cancers 52 rituximab refractory follicular 52 endometrial hyperplasia 52 BHT DNA 52 tyrosine kinase inhibitors TKIs 52 eritoran 52 pentosan 52 cilengitide 52 ARIXTRA R 52 BEXXAR Therapeutic Regimen 52 ABSSSI 52 localized prostate 52 pancreatic colon 52 Gemzar gemcitabine 52 leukemia multiple myeloma 52 DVT prophylaxis 52 Stabilimax NZ 52 Cell Lymphoma CTCL 52 HuCNS SC ® 52 pretransplant 52 multiorgan 52 gynaecologic 52 patients undergoing noncardiac 52 osteosarcomas 52 lung pancreatic 52 mutated KRAS gene 52 EGFR tyrosine kinase inhibitors 52 valopicitabine NM# 52 undergoing percutaneous coronary 52 Hepatitis C HCV 52 lumiliximab 52 refractory myeloma 52 lomitapide 52 figitumumab 52 Myelofibrosis 51 sacrocolpopexy 51 TransVax ™ 51 ganetespib 51 elacytarabine 51 neratinib 51 DACH platinum 51 Immunosuppressive 51 cerebral vasospasm 51 EGFR expressing 51 TroVax ® 51 stavudine d4T 51 anthracyclines taxanes 51 BEXXAR therapeutic regimen 51 Everolimus 51 calcineurin inhibitor 51 ultrasonographic examination 51 Behcet uveitis 51 ductal lavage 51 dose intramuscular 51 lung liver pancreas 51 non hodgkin lymphoma 51 stem cell transplantations 51 recurrent bladder 51 3D conformal radiation 51 detecting coronary artery 51 oxypurinol 51 refractory CLL 51 blood clot dissolving 51 vinflunine 51 mecasermin 51 prokinetic agent 51 Cloretazine ® 51 hepatorenal syndrome 51 novel therapeutic antibodies 51 intra abdominal infections 51 pregabalin Lyrica 51 EMPOWER TM 51 Tarvacin Anti Cancer 51 pharmacotherapeutic 51 Canvaxin TM 51 Alzhemed TM 51 coronary intervention 51 sulfonylurea metformin 51 pancreatic lung 51 partial nephrectomy 51 lipid modifying 51 ACTEMRA TM 51 Thalomid ® 51 gynecologic procedures 51 oophorectomy 51 ADVERSE EVENTS 51 post surgical adhesions 51 oxaliplatin Eloxatin 51 curative treatments 51 DCVax R 51 Recombinant interferon alpha 51 lung esophageal 51 undergoing elective 51 spiral computed tomography 51 carcinoid tumors 51 pharmacologic approaches 51 basal insulin analogue 51 vaso occlusive crisis 51 multiple myeloma MM 51 LE DT 51 novel oral anticoagulant 51 vitreoretinal disorders 51 Perceiva